|
CDK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09480002841167E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.262710E-03 |
| Normal-vs-Stage2 |
2.496400E-02 |
| Normal-vs-Stage3 |
1.6920799999931E-05 |
| Normal-vs-Stage4 |
2.442800E-03 |
| Stage1-vs-Stage2 |
4.968600E-01 |
| Stage1-vs-Stage3 |
4.782300E-04 |
| Stage1-vs-Stage4 |
9.53479999999951E-05 |
| Stage2-vs-Stage3 |
6.383000E-03 |
| Stage2-vs-Stage4 |
8.939900E-03 |
| Stage3-vs-Stage4 |
8.166000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89530000477478E-08 |
| Normal-vs-AfricanAmerican |
9.81079999999857E-05 |
| Normal-vs-Asian |
1.147390E-01 |
| Caucasian-vs-AfricanAmerican |
9.529200E-01 |
| Caucasian-vs-Asian |
8.439700E-02 |
| AfricanAmerican-vs-Asian |
3.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67139999999177E-05 |
| Normal-vs-Female |
4.32850000287033E-09 |
| Male-vs-Female |
1.201290E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.92439999999938E-05 |
| Normal-vs-Extreme_Weight |
5.896600E-03 |
| Normal-vs-Obese |
3.8733000000013E-05 |
| Normal-vs-Extreme_Obese |
8.976600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.320500E-02 |
| Normal_Weight-vs-Obese |
8.306000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.441400E-03 |
| Extreme_Weight-vs-Obese |
4.412100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.950800E-01 |
| Obese-vs-Extreme_Obese |
5.022200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.202500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.97369999957553E-07 |
| Normal-vs-Age(61-80Yrs) |
8.29700000000155E-05 |
| Normal-vs-Age(81-100Yrs) |
2.161600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.416800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.599690E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.443200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.962390E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.793400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.821400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.74699999997164E-06 |
| Normal-VS-Type2 PRCC |
4.403400E-04 |
| Normal-VS-KIRP CIMP |
3.799700E-04 |
| Normal-VS-Unclassified PRCC |
1.304360E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.638390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.401780E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.429800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.954100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.416000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.969600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.658200E-03 |
| Normal-vs-N1 |
1.70890999999784E-05 |
| Normal-vs-N2 |
4.347500E-02 |
| N0-vs-N1 |
4.634400E-04 |
| N0-vs-N2 |
3.61469999999864E-05 |
| N1-vs-N2 |
5.444500E-02 |
|
|
